BioLineRx Ltd. (BLRX) Financials

BLRX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 52.9 million 39.7 million
2023-06-30 58.9 million 37.9 million
2023-03-31 68.6 million 29.5 million
2022-12-31 76.4 million 25.5 million

BLRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -9.9 million 472000
2023-06-30 -9.8 million 485000
2023-03-31 -8.1 million 435000
2022-12-31 -5.9 million 1.0 million

BLRX Net Income

No data available :(

BLRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 26.0 million - 1.8 million
2023-06-30 32.8 million - 2.0 million
2023-03-31 43.3 million - 2.1 million
2022-12-31 51.1 million - 2.2 million

BLRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 61.9 million
2023-06-30 61.5 million
2023-03-31 61.5 million
2022-12-31 51.6 million

BLRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 27000 2.7 million 1.5 million 8.1 million
2023-06-30 123000 3.0 million 1.3 million 5.6 million
2023-03-31 129000 3.7 million 1.3 million 3.9 million
2022-12-31 228000 3.4 million 1.6 million 3.4 million

BLRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 221000
2023-06-30 - 198000
2023-03-31 - -
2022-12-31 - 187000

BLRX

Price: $0.68

52 week price:
0.58
2.53

Payout Ratio Range:
-200.00%
-16.72%

Earnings Per Share: -0.75 USD

P/E Ratio: -1.52

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 323100

Ebitda: -7.1 million

Market Capitalization: 60.9 million

Links: